Abbott Laboratories (ABT) Finished Goods (2009 - 2026)

Abbott Laboratories has disclosed Finished Goods across 18 years of filings, most recently posting $4.3 billion for Q1 2026.

• Finished Goods for Q1 2026 came in at $4.3 billion, up 5.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 billion (up 5.19% YoY), and the FY2025 annual result was $4.0 billion, up 7.46% from the prior year.
• Finished Goods came in at $4.3 billion for Q1 2026 at Abbott Laboratories, up from $4.0 billion in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $4.3 billion in Q2 2025 to a low of $3.4 billion in Q3 2022.
• The 5-year median for Finished Goods is $4.0 billion (2025), against an average of $3.9 billion.
• Across the five-year window, Finished Goods rose 23.5% in 2022 and dropped 6.23% in 2024, its largest moves.
• Abbott Laboratories' Finished Goods stood at $3.8 billion in 2022, then increased by 3.71% to $3.9 billion in 2023, then slipped by 6.23% to $3.7 billion in 2024, then increased by 7.46% to $4.0 billion in 2025, then grew by 7.49% to $4.3 billion in 2026.
• The last three Finished Goods figures came in at $4.3 billion (Q1 2026), $4.0 billion (Q4 2025), and $4.1 billion (Q3 2025), per Business Quant data.